Georgetown University licenses Alzheimer test:
This article was originally published in Clinica
Georgetown University has granted Samaritan Pharmaceuticals an exclusive, worldwide licence to its patent entitled, "Neurosteroids as markers for Alzheimer's disease". The patent relates to detection of oxidative stress in the brain, which may reflect early damage in Alzheimer's disease before the onset of symptoms. Samaritan is developing therapeutic agents for Alzheimer's disease and AIDS.